Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy.

Prondzynski M, Lemoine MD, Zech AT, Horváth A, Di Mauro V, Koivumäki JT, Kresin N, Busch J, Krause T, Krämer E, Schlossarek S, Spohn M, Friedrich FW, Münch J, Laufer SD, Redwood C, Volk AE, Hansen A, Mearini G, Catalucci D, Meyer C, Christ T, Patten M, Eschenhagen T, Carrier L.

EMBO Mol Med. 2019 Dec;11(12):e11115. doi: 10.15252/emmm.201911115. Epub 2019 Nov 3.

2.

Cardiovascular nanomedicine: the route ahead.

Iafisco M, Alogna A, Miragoli M, Catalucci D.

Nanomedicine (Lond). 2019 Sep;14(18):2391-2394. doi: 10.2217/nnm-2019-0228. Epub 2019 Aug 28. No abstract available.

3.

Wnt signalling mediates miR-133a nuclear re-localization for the transcriptional control of Dnmt3b in cardiac cells.

Di Mauro V, Crasto S, Colombo FS, Di Pasquale E, Catalucci D.

Sci Rep. 2019 Jun 27;9(1):9320. doi: 10.1038/s41598-019-45818-4.

4.

High Intensity Interval Training Ameliorates Mitochondrial Dysfunction in the Left Ventricle of Mice with Type 2 Diabetes.

Bækkerud FH, Salerno S, Ceriotti P, Morland C, Storm-Mathisen J, Bergersen LH, Høydal MA, Catalucci D, Stølen TO.

Cardiovasc Toxicol. 2019 Oct;19(5):422-431. doi: 10.1007/s12012-019-09514-z.

PMID:
30927207
5.

The noncoding-RNA landscape in cardiovascular health and disease.

Di Mauro V, Barandalla-Sobrados M, Catalucci D.

Noncoding RNA Res. 2018 Feb 9;3(1):12-19. doi: 10.1016/j.ncrna.2018.02.001. eCollection 2018 Mar. Review.

6.

A combined low-frequency electromagnetic and fluidic stimulation for a controlled drug release from superparamagnetic calcium phosphate nanoparticles: potential application for cardiovascular diseases.

Marrella A, Iafisco M, Adamiano A, Rossi S, Aiello M, Barandalla-Sobrados M, Carullo P, Miragoli M, Tampieri A, Scaglione S, Catalucci D.

J R Soc Interface. 2018 Jul;15(144). pii: 20180236. doi: 10.1098/rsif.2018.0236.

7.

MicroRNA-199a-3p and MicroRNA-199a-5p Take Part to a Redundant Network of Regulation of the NOS (NO Synthase)/NO Pathway in the Endothelium.

Joris V, Gomez EL, Menchi L, Lobysheva I, Di Mauro V, Esfahani H, Condorelli G, Balligand JL, Catalucci D, Dessy C.

Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2345-2357. doi: 10.1161/ATVBAHA.118.311145.

PMID:
29976767
8.

An anti-PDGFRβ aptamer for selective delivery of small therapeutic peptide to cardiac cells.

Romanelli A, Affinito A, Avitabile C, Catuogno S, Ceriotti P, Iaboni M, Modica J, Condorelli G, Catalucci D.

PLoS One. 2018 Mar 7;13(3):e0193392. doi: 10.1371/journal.pone.0193392. eCollection 2018.

9.

Inhalation of peptide-loaded nanoparticles improves heart failure.

Miragoli M, Ceriotti P, Iafisco M, Vacchiano M, Salvarani N, Alogna A, Carullo P, Ramirez-Rodríguez GB, Patrício T, Esposti LD, Rossi F, Ravanetti F, Pinelli S, Alinovi R, Erreni M, Rossi S, Condorelli G, Post H, Tampieri A, Catalucci D.

Sci Transl Med. 2018 Jan 17;10(424). pii: eaan6205. doi: 10.1126/scitranslmed.aan6205.

PMID:
29343624
10.

Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy.

Zaglia T, Ceriotti P, Campo A, Borile G, Armani A, Carullo P, Prando V, Coppini R, Vida V, Stølen TO, Ulrik W, Cerbai E, Stellin G, Faggian G, De Stefani D, Sandri M, Rizzuto R, Di Lisa F, Pozzan T, Catalucci D, Mongillo M.

Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):E9006-E9015. doi: 10.1073/pnas.1708772114. Epub 2017 Oct 9.

11.

Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction.

De Pauw A, Andre E, Sekkali B, Bouzin C, Esfahani H, Barbier N, Loriot A, De Smet C, Vanhoutte L, Moniotte S, Gerber B, di Mauro V, Catalucci D, Feron O, Hilfiker-Kleiner D, Balligand JL.

JCI Insight. 2017 Jun 15;2(12). pii: 91810. doi: 10.1172/jci.insight.91810. eCollection 2017 Jun 15.

12.

The importance of being ncRNAs: from bit players as "junk DNA" to rising stars on the stage of the pharmaceutical industry.

Di Mauro V, Catalucci D.

Ann Transl Med. 2017 Mar;5(6):147. doi: 10.21037/atm.2017.01.20. No abstract available.

13.

T cell costimulation blockade blunts pressure overload-induced heart failure.

Kallikourdis M, Martini E, Carullo P, Sardi C, Roselli G, Greco CM, Vignali D, Riva F, Ormbostad Berre AM, Stølen TO, Fumero A, Faggian G, Di Pasquale E, Elia L, Rumio C, Catalucci D, Papait R, Condorelli G.

Nat Commun. 2017 Mar 6;8:14680. doi: 10.1038/ncomms14680.

14.

MiR-153/Kv7.4: a novel molecular axis in the regulation of hypertension.

Maffei A, Di Mauro V, Catalucci D, Lembo G.

Cardiovasc Res. 2016 Nov 1;112(2):530-531. doi: 10.1093/cvr/cvw208. No abstract available.

PMID:
27635057
15.

Peptidomimetic Targeting of Cavβ2 Overcomes Dysregulation of the L-Type Calcium Channel Density and Recovers Cardiac Function.

Rusconi F, Ceriotti P, Miragoli M, Carullo P, Salvarani N, Rocchetti M, Di Pasquale E, Rossi S, Tessari M, Caprari S, Cazade M, Kunderfranco P, Chemin J, Bang ML, Polticelli F, Zaza A, Faggian G, Condorelli G, Catalucci D.

Circulation. 2016 Aug 16;134(7):534-46. doi: 10.1161/CIRCULATIONAHA.116.021347. Epub 2016 Aug 2.

PMID:
27486162
16.

Exercise training reverses myocardial dysfunction induced by CaMKIIδC overexpression by restoring Ca2+ homeostasis.

Høydal MA, Stølen TO, Kettlewell S, Maier LS, Brown JH, Sowa T, Catalucci D, Condorelli G, Kemi OJ, Smith GL, Wisløff U.

J Appl Physiol (1985). 2016 Jul 1;121(1):212-20. doi: 10.1152/japplphysiol.00188.2016. Epub 2016 May 26.

17.

Bioinspired negatively charged calcium phosphate nanocarriers for cardiac delivery of MicroRNAs.

Di Mauro V, Iafisco M, Salvarani N, Vacchiano M, Carullo P, Ramírez-Rodríguez GB, Patrício T, Tampieri A, Miragoli M, Catalucci D.

Nanomedicine (Lond). 2016 Apr;11(8):891-906. doi: 10.2217/nnm.16.26. Epub 2016 Mar 16.

18.

Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin.

Zenaro E, Pietronigro E, Della Bianca V, Piacentino G, Marongiu L, Budui S, Turano E, Rossi B, Angiari S, Dusi S, Montresor A, Carlucci T, Nanì S, Tosadori G, Calciano L, Catalucci D, Berton G, Bonetti B, Constantin G.

Nat Med. 2015 Aug;21(8):880-6. doi: 10.1038/nm.3913. Epub 2015 Jul 27.

PMID:
26214837
19.

MicroRNA-133 modulates the β1-adrenergic receptor transduction cascade.

Castaldi A, Zaglia T, Di Mauro V, Carullo P, Viggiani G, Borile G, Di Stefano B, Schiattarella GG, Gualazzi MG, Elia L, Stirparo GG, Colorito ML, Pironti G, Kunderfranco P, Esposito G, Bang ML, Mongillo M, Condorelli G, Catalucci D.

Circ Res. 2014 Jul 7;115(2):273-83. doi: 10.1161/CIRCRESAHA.115.303252. Epub 2014 May 7.

PMID:
24807785
20.

Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy.

Zaglia T, Milan G, Ruhs A, Franzoso M, Bertaggia E, Pianca N, Carpi A, Carullo P, Pesce P, Sacerdoti D, Sarais C, Catalucci D, Krüger M, Mongillo M, Sandri M.

J Clin Invest. 2014 Jun;124(6):2410-24. doi: 10.1172/JCI66339. Epub 2014 May 1.

21.

Reduced aerobic capacity causes leaky ryanodine receptors that trigger arrhythmia in a rat strain artificially selected and bred for low aerobic running capacity.

Høydal MA, Stølen TO, Johnsen AB, Alvez M, Catalucci D, Condorelli G, Koch LG, Britton SL, Smith GL, Wisløff U.

Acta Physiol (Oxf). 2014 Apr;210(4):854-64. doi: 10.1111/apha.12238. Epub 2014 Feb 25.

22.

MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts.

Curcio A, Torella D, Iaconetti C, Pasceri E, Sabatino J, Sorrentino S, Giampà S, Micieli M, Polimeni A, Henning BJ, Leone A, Catalucci D, Ellison GM, Condorelli G, Indolfi C.

PLoS One. 2013 Jul 26;8(7):e70158. doi: 10.1371/journal.pone.0070158. Print 2013.

23.

Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1.

Yildirim SS, Akman D, Catalucci D, Turan B.

Cell Biochem Biophys. 2013;67(3):1397-408. doi: 10.1007/s12013-013-9672-y.

PMID:
23723006
24.

HEXIM1: a new player in myocardial hypertrophy?

Catalucci D, Condorelli G.

Cardiovasc Res. 2013 Jul 1;99(1):1-3. doi: 10.1093/cvr/cvt134. Epub 2013 May 29. No abstract available.

PMID:
23720275
25.

An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart.

Tritsch E, Mallat Y, Lefebvre F, Diguet N, Escoubet B, Blanc J, De Windt LJ, Catalucci D, Vandecasteele G, Li Z, Mericskay M.

Cardiovasc Res. 2013 Jun 1;98(3):372-80. doi: 10.1093/cvr/cvt042. Epub 2013 Feb 22.

PMID:
23436819
26.

NF-κB mediated miR-26a regulation in cardiac fibrosis.

Wei C, Kim IK, Kumar S, Jayasinghe S, Hong N, Castoldi G, Catalucci D, Jones WK, Gupta S.

J Cell Physiol. 2013 Jul;228(7):1433-42. doi: 10.1002/jcp.24296.

PMID:
23254997
27.

Mutual antagonism between IP(3)RII and miRNA-133a regulates calcium signals and cardiac hypertrophy.

Drawnel FM, Wachten D, Molkentin JD, Maillet M, Aronsen JM, Swift F, Sjaastad I, Liu N, Catalucci D, Mikoshiba K, Hisatsune C, Okkenhaug H, Andrews SR, Bootman MD, Roderick HL.

J Cell Biol. 2012 Nov 26;199(5):783-98. doi: 10.1083/jcb.201111095. Epub 2012 Nov 19.

28.

The circulating level of FABP3 is an indirect biomarker of microRNA-1.

Varrone F, Gargano B, Carullo P, Di Silvestre D, De Palma A, Grasso L, Di Somma C, Mauri P, Benazzi L, Franzone A, Jotti GS, Bang ML, Esposito G, Colao A, Condorelli G, Catalucci D.

J Am Coll Cardiol. 2013 Jan 8;61(1):88-95. doi: 10.1016/j.jacc.2012.08.1003. Epub 2012 Nov 7.

29.

APJ acts as a dual receptor in cardiac hypertrophy.

Scimia MC, Hurtado C, Ray S, Metzler S, Wei K, Wang J, Woods CE, Purcell NH, Catalucci D, Akasaka T, Bueno OF, Vlasuk GP, Kaliman P, Bodmer R, Smith LH, Ashley E, Mercola M, Brown JH, Ruiz-Lozano P.

Nature. 2012 Aug 16;488(7411):394-8. doi: 10.1038/nature11263.

30.

Altered β-adrenergic response in mice lacking myotonic dystrophy protein kinase.

Llagostera E, Álvarez López MJ, Scimia C, Catalucci D, Párrizas M, Ruiz-Lozano P, Kaliman P.

Muscle Nerve. 2012 Jan;45(1):128-30. doi: 10.1002/mus.22256.

31.

MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo.

Torella D, Iaconetti C, Catalucci D, Ellison GM, Leone A, Waring CD, Bochicchio A, Vicinanza C, Aquila I, Curcio A, Condorelli G, Indolfi C.

Circ Res. 2011 Sep 30;109(8):880-93. doi: 10.1161/CIRCRESAHA.111.240150. Epub 2011 Aug 18.

32.

MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension.

Castoldi G, Di Gioia CR, Bombardi C, Catalucci D, Corradi B, Gualazzi MG, Leopizzi M, Mancini M, Zerbini G, Condorelli G, Stella A.

J Cell Physiol. 2012 Feb;227(2):850-6. doi: 10.1002/jcp.22939.

PMID:
21769867
33.

A comparative MudPIT analysis identifies different expression profiles in heart compartments.

Comunian C, Rusconi F, De Palma A, Brunetti P, Catalucci D, Mauri PL.

Proteomics. 2011 Jun;11(11):2320-8. doi: 10.1002/pmic.201000479. Epub 2011 May 20.

PMID:
21598388
34.

MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice.

Zhang D, Contu R, Latronico MV, Zhang J, Rizzi R, Catalucci D, Miyamoto S, Huang K, Ceci M, Gu Y, Dalton ND, Peterson KL, Guan KL, Brown JH, Chen J, Sonenberg N, Condorelli G.

J Clin Invest. 2010 Aug;120(8):2805-16. doi: 10.1172/JCI43008. Epub 2010 Jul 19. Erratum in: J Clin Invest. 2010 Oct 1;120(10):3735. Zhang, Jian Ling [corrected to Zhang, Jianlin].

35.

Immersion before dry simulated dive reduces cardiomyocyte function and increases mortality after decompression.

Gaustad SE, Brubakk AO, Høydal M, Catalucci D, Condorelli G, Dujic Z, Marinovic J, Ljubkovic M, Møllerløkken A, Wisløff U.

J Appl Physiol (1985). 2010 Sep;109(3):752-7. doi: 10.1152/japplphysiol.01257.2009. Epub 2010 Jul 15.

36.

MicroRNAs in cardiovascular biology and heart disease.

Catalucci D, Gallo P, Condorelli G.

Circ Cardiovasc Genet. 2009 Aug;2(4):402-8. doi: 10.1161/CIRCGENETICS.109.857425. Review.

PMID:
20031613
37.

Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions.

Elia L, Contu R, Quintavalle M, Varrone F, Chimenti C, Russo MA, Cimino V, De Marinis L, Frustaci A, Catalucci D, Condorelli G.

Circulation. 2009 Dec 8;120(23):2377-85. doi: 10.1161/CIRCULATIONAHA.109.879429. Epub 2009 Nov 23.

38.

The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease.

Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV, Peterson KL, Indolfi C, Catalucci D, Chen J, Courtneidge SA, Condorelli G.

Cell Death Differ. 2009 Dec;16(12):1590-8. doi: 10.1038/cdd.2009.153. Epub 2009 Oct 9.

39.

Akt increases sarcoplasmic reticulum Ca2+ cycling by direct phosphorylation of phospholamban at Thr17.

Catalucci D, Latronico MV, Ceci M, Rusconi F, Young HS, Gallo P, Santonastasi M, Bellacosa A, Brown JH, Condorelli G.

J Biol Chem. 2009 Oct 9;284(41):28180-7. doi: 10.1074/jbc.M109.036566. Epub 2009 Aug 19.

40.

Interval training normalizes cardiomyocyte function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model of diabetic cardiomyopathy.

Stølen TO, Høydal MA, Kemi OJ, Catalucci D, Ceci M, Aasum E, Larsen T, Rolim N, Condorelli G, Smith GL, Wisløff U.

Circ Res. 2009 Sep 11;105(6):527-36. doi: 10.1161/CIRCRESAHA.109.199810. Epub 2009 Aug 13.

PMID:
19679837
41.

Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability.

Catalucci D, Zhang DH, DeSantiago J, Aimond F, Barbara G, Chemin J, Bonci D, Picht E, Rusconi F, Dalton ND, Peterson KL, Richard S, Bers DM, Brown JH, Condorelli G.

J Cell Biol. 2009 Mar 23;184(6):923-33. doi: 10.1083/jcb.200805063. Erratum in: J Cell Biol. 2013 Mar 18;200(6):851.

42.

Gene expression profiling of skeletal muscle in exercise-trained and sedentary rats with inborn high and low VO2max.

Bye A, Høydal MA, Catalucci D, Langaas M, Kemi OJ, Beisvag V, Koch LG, Britton SL, Ellingsen Ø, Wisløff U.

Physiol Genomics. 2008 Nov 12;35(3):213-21. doi: 10.1152/physiolgenomics.90282.2008. Epub 2008 Sep 9.

43.

MicroRNA and cardiac pathologies.

Latronico MV, Catalucci D, Condorelli G.

Physiol Genomics. 2008 Aug 15;34(3):239-42. doi: 10.1152/physiolgenomics.90254.2008. Epub 2008 Jun 10. Review.

PMID:
18544659
44.

Heart failure: targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment.

Latronico MV, Elia L, Condorelli G, Catalucci D.

Int J Biochem Cell Biol. 2008;40(9):1643-8. doi: 10.1016/j.biocel.2008.03.002. Epub 2008 Mar 18. Review.

PMID:
18514564
45.

MicroRNAs: novel regulators in cardiac development and disease.

Thum T, Catalucci D, Bauersachs J.

Cardiovasc Res. 2008 Sep 1;79(4):562-70. doi: 10.1093/cvr/cvn137. Epub 2008 May 29. Review.

PMID:
18511432
46.

Carbon monoxide levels experienced by heavy smokers impair aerobic capacity and cardiac contractility and induce pathological hypertrophy.

Bye A, Sørhaug S, Ceci M, Høydal MA, Stølen T, Heinrich G, Tjønna AE, Najjar SM, Nilsen OG, Catalucci D, Grimaldi S, Contu R, Steinshamn S, Condorelli G, Smith GL, Ellingsen O, Waldum H, Wisløff U.

Inhal Toxicol. 2008 May;20(7):635-46. doi: 10.1080/08958370701883821 .

PMID:
18464052
47.

MicroRNAs control gene expression: importance for cardiac development and pathophysiology.

Catalucci D, Latronico MV, Condorelli G.

Ann N Y Acad Sci. 2008 Mar;1123:20-9. doi: 10.1196/annals.1420.004. Review.

PMID:
18375574
48.

Deciphering the beta-adrenergic response in human embryonic stem cell-derived-cardiac myocytes: closer to clinical use?

Catalucci D, Bang ML, Condorelli G.

Br J Pharmacol. 2008 Feb;153(4):625-6. doi: 10.1038/sj.bjp.0707633. Epub 2008 Jan 14. Erratum in: Br J Pharmacol. 2008 Apr;153(8):1765.

49.

Emerging role of microRNAs in cardiovascular biology.

Latronico MV, Catalucci D, Condorelli G.

Circ Res. 2007 Dec 7;101(12):1225-36. Review.

PMID:
18063818
50.

Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action.

Llagostera E, Catalucci D, Marti L, Liesa M, Camps M, Ciaraldi TP, Kondo R, Reddy S, Dillmann WH, Palacin M, Zorzano A, Ruiz-Lozano P, Gomis R, Kaliman P.

PLoS One. 2007 Nov 7;2(11):e1134.

Supplemental Content

Loading ...
Support Center